Common Antidepressants May Prevent Beta-Amyloid Aggregates in Alzheimer’s, Study Reports

Common Antidepressants May Prevent Beta-Amyloid Aggregates in Alzheimer’s, Study Reports
Commonly used antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, can prevent beta-amyloid aggregation, representing a potential new therapeutic strategy for Alzheimer’s disease, a study suggests. The study, “Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid,” was published in ACS Chemical Neuroscience. The process of developing and approving new therapies is very expensive, but more

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *